Transcriptional activation of the Pirb gene in B cells by PU.1 and Runx3

Journal of Immunology

Volumn 186, Issue 12, 2011, Pages 7050-7059

  Arita, Kojo ^a   Endo, Shota ^a   Kaifu, Tomonori ^a   Kitaguchi, Kohji ^a   Nakamura, Akira ^a   Ohmori, Hidetaka ^a   Kohu, Kazuyoshi ^a   Satake, Masanobu ^a   Takai, Toshiyuki ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; TRANSCRIPTION FACTOR PU 1; TRANSCRIPTION FACTOR RUNX3;

ANIMAL CELL; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CODON; CONTROLLED STUDY; GENE LOCATION; GENE SILENCING; GENE TARGETING; LEUKEMIA CELL LINE; LYMPHOMA CELL LINE; MOUSE; NONHUMAN; PIRA GENE; PIRB GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN MOTIF; RECEPTOR GENE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TRANSLATION INITIATION;

ANIMALS; B-LYMPHOCYTES; BINDING SITES; CELL LINE, TUMOR; CORE BINDING FACTOR ALPHA 3 SUBUNIT; LYMPHOMA, B-CELL; MICE; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; RECEPTORS, IMMUNOLOGIC; TRANS-ACTIVATORS; TRANSCRIPTIONAL ACTIVATION;

EID: 79959565853     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001302     Document Type: Article

References (77)

1. Gessner, J. E., H. Heiken, A. Tamm, and R. E. Schmidt. 1998. The IgG Fc receptor family. Ann. Hematol. 76: 231-248.
2. Nimmerjahn, F., and J. V. Ravetch. 2008. Fcgamma receptors as regulators of immune responses. Nat. Rev. Immunol. 8: 34-47.
3. Ravetch, J. V., and S. Bolland. 2001. IgG Fc receptors. Annu. Rev. Immunol. 19: 275-290.
4. Bolland, S., and J. V. Ravetch. 2000. Spontaneous autoimmune disease in Fc (γ)RIIB-deficient mice results from strain-specific epistasis. Immunity 13: 277-285.
5. Takai, T., M. Ono, M. Hikida, H. Ohmori, and J. V. Ravetch. 1996. Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. Nature 379: 346-349.
6. Takai, T. 2002. Roles of Fc receptors in autoimmunity. Nat. Rev. Immunol. 2: 580-592.
7. Hayami, K., D. Fukuta, Y. Nishikawa, Y. Yamashita, M. Inui, Y. Ohyama, M. Hikida, H. Ohmori, and T. Takai. 1997. Molecular cloning of a novel murine cell-surface glycoprotein homologous to killer cell inhibitory receptors. J. Biol. Chem. 272: 7320-7327.
8. Kubagawa, H., P. D. Burrows, and M. D. Cooper. 1997. A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. Proc. Natl. Acad. Sci. USA 94: 5261-5266.
9. Kubagawa, H., C. C. Chen, L. H. Ho, T. S. Shimada, L. Gartland, C. Mashburn, T. Uehara, J. V. Ravetch, and M. D. Cooper. 1999. Biochemical nature and cellular distribution of the paired immunoglobulin-like receptors, PIR-A and PIR-B. J. Exp. Med. 189: 309-318.
10. Yamashita, Y., D. Fukuta, A. Tsuji, A. Nagabukuro, Y. Matsuda, Y. Nishikawa, Y. Ohyama, H. Ohmori, M. Ono, and T. Takai. 1998. Genomic structures and chromosomal location of p91, a novel murine regulatory receptor family. J. Biochem. 123: 358-368. (Pubitemid 28120773)
11. Yamashita, Y., M. Ono, and T. Takai. 1998. Inhibitory and stimulatory functions of paired Ig-like receptor (PIR) family in RBL-2H3 cells. J. Immunol. 161: 4042-4047. (Pubitemid 28468982)
12. -/- mice. Nat. Immunol. 5: 623-629.
13. Takai, T. 2005. Paired immunoglobulin-like receptors and their MHC class I recognition. Immunology 115: 433-440. (Pubitemid 41032431)
14. Takai, T. 2005. A novel recognition system for MHC class I molecules constituted by PIR. Adv. Immunol. 88: 161-192.
15. Bléry, M., H. Kubagawa, C. C. Chen, F. Vély, M. D. Cooper, and E. Vivier. 1998. The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1. Proc. Natl. Acad. Sci. USA 95: 2446-2451.
16. Maeda, A., M. Kurosaki, M. Ono, T. Takai, and T. Kurosaki. 1998. Requirement of SH2-containing protein tyrosine phosphatases SHP-1 and SHP-2 for paired immunoglobulin-like receptor B (PIR-B)-mediated inhibitory signal. J. Exp. Med. 187: 1355-1360.
17. Masuda, A., A. Nakamura, T. Maeda, Y. Sakamoto, and T. Takai. 2007. Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation. J. Exp. Med. 204: 907-920.
18. Endo, S., Y. Sakamoto, E. Kobayashi, A. Nakamura, and T. Takai. 2008. Regulation of cytotoxic T lymphocyte triggering by PIR-B on dendritic cells. Proc. Natl. Acad. Sci. USA 105: 14515-14520.
19. Imada, M., K. Masuda, R. Satoh, Y. Ito, Y. Goto, T. Matsuoka, S. Endo, A. Nakamura, H. Kawamoto, and T. Takai. 2009. Ectopically expressed PIR-B on T cells constitutively binds to MHC class I and attenuates T helper type 1 responses. Int. Immunol. 21: 1151-1161.
20. Atwal, J. K., J. Pinkston-Gosse, J. Syken, S. Stawicki, Y. Wu, C. Shatz, and M. Tessier-Lavigne. 2008. PirB is a functional receptor for myelin inhibitors of axonal regeneration. Science 322: 967-970.
21. Syken, J., T. Grandpre, P. O. Kanold, and C. J. Shatz. 2006. PirB restricts ocular-dominance plasticity in visual cortex. Science 313: 1795-1800.
22. Boulanger, L. M. 2009. Immune proteins in brain development and synaptic plasticity. Neuron 64: 93-109.
23. Koga, T., M. Inui, K. Inoue, S. Kim, A. Suematsu, E. Kobayashi, T. Iwata, H. Ohnishi, T. Matozaki, T. Kodama, et al. 2004. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428: 758-763. (Pubitemid 38508286)
24. Uehara, T., M. Bléry, D.-W. Kang, C.-C. Chen, L. H. Ho, G. L. Gartland, F.-T. Liu, E. Vivier, M. D. Cooper, and H. Kubagawa. 2001. Inhibition of IgE-mediated mast cell activation by the paired Ig-like receptor PIR-B. J. Clin. Invest. 108: 1041-1050.
25. Nakayama, M., D. M. Underhill, T. W. Petersen, B. Li, T. Kitamura, T. Takai, and A. Aderem. 2007. Paired Ig-like receptors bind to bacteria and shape TLR-mediated cytokine production. J. Immunol. 178: 4250-4259. (Pubitemid 46492375)
26. Torii, I., S. Oka, M. Hotomi, W. H. Benjamin, Jr., T. Takai, J. F. Kearney, D. E. Briles, and H. Kubagawa. 2008. PIR-B-deficient mice are susceptible to Salmonella infection. J. Immunol. 181: 4229-4239.
27. Kubo, T., Y. Uchida, Y. Watanabe, M. Abe, A. Nakamura, M. Ono, S. Akira, and T. Takai. 2009. Augmented TLR9-induced Btk activation in PIR-B-deficient B-1 cells provides excessive autoantibody production and autoimmunity. J. Exp. Med. 206: 1971-1982.
28. Munitz, A., M. L. McBride, J. S. Bernstein, and M. E. Rothenberg. 2008. A dual activation and inhibition role for the paired immunoglobulin-like receptor B in eosinophils. Blood 111: 5694-5703.
29. Zhang, H., F. Meng, C.-L. Chu, T. Takai, and C. A. Lowell. 2005. The Src family kinases Hck and Fgr negatively regulate neutrophil and dendritic cell chemokine signaling via PIR-B. Immunity 22: 235-246.
30. Pereira, S., H. Zhang, T. Takai, and C. A. Lowell. 2004. The inhibitory receptor PIR-B negatively regulates neutrophil and macrophage integrin signaling. J. Immunol. 173: 5757-5765.
31. Alley, T. L., M. D. Cooper, M. Chen, and H. Kubagawa. 1998. Genomic structure of PIR-B, the inhibitory member of the paired immunoglobulin-like receptor genes in mice. Tissue Antigens 51: 224-231. (Pubitemid 28112456)
32. Tun, T., Y. Kubagawa, G. Dennis, P. D. Burrows, M. D. Cooper, and H. Kubagawa. 2003. Genomic structure of mouse PIR-A6, an activating member of the paired immunoglobulin-like receptor gene family. Tissue Antigens 61: 220-230. (Pubitemid 36605544)
33. Kohu, K., H. Ohmori, W. F. Wong, D. Onda, T. Wakoh, S. Kon, M. Yamashita, T. Nakayama, M. Kubo, and M. Satake. 2009. The Runx3 transcription factor augments Th1 and down-modulates Th2 phenotypes by interacting with and attenuating GATA3. J. Immunol. 183: 7817-7824.
34. Kohu, K., T. Sato, S. Ohno, K. Hayashi, R. Uchino, N. Abe, M. Nakazato, N. Yoshida, T. Kikuchi, Y. Iwakura, et al. 2005. Overexpression of the Runx3 transcription factor increases the proportion of mature thymocytes of the CD8 single-positive lineage. J. Immunol. 174: 2627-2636. (Pubitemid 40279676)
35. Maeda, A., M. Kurosaki, and T. Kurosaki. 1998. Paired immunoglobulin-like receptor (PIR)-A is involved in activating mast cells through its association with Fc receptor γ chain. J. Exp. Med. 188: 991-995.
36. Taylor, L. S., and D. W. McVicar. 1999. Functional association of FcepsilonRIgamma with arginine(632) of paired immunoglobulin-like receptor (PIR)-A3 in murine macrophages. Blood 94: 1790-1796.
37. Ono, M., T. Yuasa, C. Ra, and T. Takai. 1999. Stimulatory function of paired immunoglobulin-like receptor-A in mast cell line by associating with subunits common to Fc receptors. J. Biol. Chem. 274: 30288-30296.
38. DeKoter, R. P., and H. Singh. 2000. Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science 288: 1439-1441.
39. (-/-) mice. Nat. Immunol. 3: 542-548.
40. Scott, E. W., M. C. Simon, J. Anastasi, and H. Singh. 1994. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265: 1573-1577.
41. Olson, M. C., E. W. Scott, A. A. Hack, G. H. Su, D. G. Tenen, H. Singh, and M. C. Simon. 1995. PU.1 is not essential for early myeloid gene expression but is required for terminal myeloid differentiation. Immunity 3: 703-714.
42. McKercher, S. R., B. E. Torbett, K. L. Anderson, G. W. Henkel, D. J. Vestal, H. Baribault, M. Klemsz, A. J. Feeney, G. E. Wu, C. J. Paige, and R. A. Maki. 1996. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15: 5647-5658.
43. Anderson, K. L., K. A. Smith, K. Conners, S. R. McKercher, R. A. Maki, and B. E. Torbett. 1998. Myeloid development is selectively disrupted in PU.1 null mice. Blood 91: 3702-3710.
44. Rosenbauer, F., B. M. Owens, L. Yu, J. R. Tumang, U. Steidl, J. L. Kutok, L. K. Clayton, K. Wagner, M. Scheller, H. Iwasaki, et al. 2006. Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1. Nat. Genet. 38: 27-37.
45. Taniuchi, I., M. Osato, T. Egawa, M. J. Sunshine, S. C. Bae, T. Komori, Y. Ito, and D. R. Littman. 2002. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 111: 621-633.
46. Woolf, E., C. Xiao, O. Fainaru, J. Lotem, D. Rosen, V. Negreanu, Y. Bernstein, D. Goldenberg, O. Brenner, G. Berke, et al. 2003. Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis. Proc. Natl. Acad. Sci. USA 100: 7731-7736.
47. Sato, T., S. Ohno, T. Hayashi, C. Sato, K. Kohu, M. Satake, and S. Habu. 2005. Dual functions of Runx proteins for reactivating CD8 and silencing CD4 at the commitment process into CD8 thymocytes. Immunity 22: 317-328. (Pubitemid 40387474)
48. Djuretic, I. M., D. Levanon, V. Negreanu, Y. Groner, A. Rao, and K. M. Ansel. 2007. Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells. Nat. Immunol. 8: 145-153.
49. Fainaru, O., E. Woolf, J. Lotem, M. Yarmus, O. Brenner, D. Goldenberg, V. Negreanu, Y. Bernstein, D. Levanon, S. Jung, and Y. Groner. 2004. Runx3 regulates mouse TGF-b-mediated dendritic cell function and its absence results in airway inflammation. EMBO J. 23: 969-979. (Pubitemid 38418763)
50. Kim, W. Y., M. Sieweke, E. Ogawa, H. J. Wee, U. Englmeier, T. Graf, and Y. Ito. 1999. Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains. EMBO J. 18: 1609-1620. (Pubitemid 29127073)
51. Zhang, D. E., C. J. Hetherington, S. Meyers, K. L. Rhoades, C. J. Larson, H. M. Chen, S. W. Hiebert, and D. G. Tenen. 1996. CCAAT enhancer-binding protein (C/EBP) and AML1 (CBF α2) synergistically activate the macrophage colony-stimulating factor receptor promoter. Mol. Cell. Biol. 16: 1231-1240.
52. Sun, W., B. J. Graves, and N. A. Speck. 1995. Transactivation of the Moloney murine leukemia virus and T-cell receptor beta-chain enhancers by cbf and ets requires intact binding sites for both proteins. J. Virol. 69: 4941-4949.
53. Giese, K., C. Kingsley, J. R. Kirshner, and R. Grosschedl. 1995. Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes Dev. 9: 995-1008.
54. Chang, H. C., L. Han, R. Jabeen, S. Carotta, S. L. Nutt, and M. H. Kaplan. 2009. PU.1 regulates TCR expression by modulating GATA-3 activity. J. Immunol. 183: 4887-4894.
55. Ho, I. C., N. K. Bhat, L. R. Gottschalk, T. Lindsten, C. B. Thompson, T. S. Papas, and J. M. Leiden. 1990. Sequence-specific binding of human Ets-1 to the T cell receptor α gene enhancer. Science 250: 814-818.
56. Halle, J. P., P. Haus-Seuffert, C. Woltering, G. Stelzer, and M. Meisterernst. 1997. A conserved tissue-specific structure at a human T-cell receptor β-chain core promoter. Mol. Cell. Biol. 17: 4220-4229.
57. Shi, M. J., S. R. Park, P. H. Kim, and J. Stavnezer. 2001. Roles of Ets proteins, NF-κB and nocodazole in regulating induction of transcription of mouse germline Ig a RNA by transforming growth factor-β 1. Int. Immunol. 13: 733-746.
58. Xie, X. Q., E. Pardali, M. Holm, P. Sideras, and T. Grundström. 1999. AML and Ets proteins regulate the I alpha1 germ-line promoter. Eur. J. Immunol. 29: 488-498.
59. Friedman, A. D. 2002. Transcriptional regulation of granulocyte and monocyte development. Oncogene 21: 3377-3390. (Pubitemid 34587710)
60. Oikawa, T., and T. Yamada. 2003. Molecular biology of the Ets family of transcription factors. Gene 303: 11-34. (Pubitemid 36151767)
61. Petrovick, M. S., S. W. Hiebert, A. D. Friedman, C. J. Hetherington, D. G. Tenen, and D. E. Zhang. 1998. Multiple functional domains of AML1: PU.1 and C/EBPalpha synergize with different regions of AML1. Mol. Cell. Biol. 18: 3915-3925.
62. Zamisch, M., L. Tian, R. Grenningloh, Y. Xiong, K. F. Wildt, M. Ehlers, I. C. Ho, and R. Bosselut. 2009. The transcription factor Ets1 is important for CD4 repression and Runx3 up-regulation during CD8 T cell differentiation in the thymus. J. Exp. Med. 206: 2685-2699.
63. Delogu, A., A. Schebesta, Q. Sun, K. Aschenbrenner, T. Perlot, and M. Busslinger. 2006. Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells. Immunity 24: 269-281.
64. Ho, L. H., T. Uehara, C. C. Chen, H. Kubagawa, and M. D. Cooper. 1999. Constitutive tyrosine phosphorylation of the inhibitory paired Ig-like receptor PIR-B. Proc. Natl. Acad. Sci. USA 96: 15086-15090.
65. Rudge, E. U., A. J. Cutler, N. R. Pritchard, and K. G. Smith. 2002. Interleukin 4 reduces expression of inhibitory receptors on B cells and abolishes CD22 and FcγRII-mediated B cell suppression. J. Exp. Med. 195: 1079-1085.
66. Colonna, M., and J. Samaridis. 1995. Cloning of immunoglobulin- superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 268: 405-408.
67. Samaridis, J., and M. Colonna. 1997. Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: structural evidence for new stimulatory and inhibitory pathways. Eur. J. Immunol. 27: 660-665.
68. Colonna, M., H. Nakajima, F. Navarro, and M. López-Botet. 1999. A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells. J. Leukoc. Biol. 66: 375-381.
69. Cosman, D., N. Fanger, L. Borges, M. Kubin, W. Chin, L. Peterson, and M. L. Hsu. 1997. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7: 273-282.
70. Borges, L., M. L. Hsu, N. Fanger, M. Kubin, and D. Cosman. 1997. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J. Immunol. 159: 5192-5196. (Pubitemid 127470042)
71. Fanger, N. A., L. Borges, and D. Cosman. 1999. The leukocyte immunoglobulinlike receptors (LIRs): a new family of immune regulators. J. Leukoc. Biol. 66: 231-236.
72. Wagtmann, N., S. Rojo, E. Eichler, H. Mohrenweiser, and E. O. Long. 1997. A new human gene complex encoding the killer cell inhibitory receptors and related monocyte/macrophage receptors. Curr. Biol. 7: 615-618.
73. Arm, J. P., C. Nwankwo, and K. F. Austen. 1997. Molecular identification of a novel family of human Ig superfamily members that possess immunoreceptor tyrosine-based inhibition motifs and homology to the mouse gp49B1 inhibitory receptor. J. Immunol. 159: 2342-2349.
74. Moretta, A., C. Bottino, M. Vitale, D. Pende, R. Biassoni, M. C. Mingari, and L. Moretta. 1996. Receptors for HLA class-I molecules in human natural killer cells. Annu. Rev. Immunol. 14: 619-648.
75. Nakajima, H., A. Asai, A. Okada, L. Ping, F. Hamajima, T. Sata, and K. Isobe. 2003. Transcriptional regulation of ILT family receptors. J. Immunol. 171: 6611-6620. (Pubitemid 37532093)
76. Trompeter, H. I., N. Gómez-Lozano, S. Santourlidis, B. Eisermann, P. Wernet, C. Vilches, and M. Uhrberg. 2005. Three structurally and functionally divergent kinds of promoters regulate expression of clonally distributed killer cell Ig-like receptors (KIR), of KIR2DL4, and of KIR3DL3. J. Immunol. 174: 4135-4143. (Pubitemid 40395991)
77. Presnell, S. R., L. Zhang, C. A. Ramilo, H. W. Chan, and C. T. Lutz. 2006. Functional redundancy of transcription factor-binding sites in the killer cell Iglike receptor (KIR) gene promoter. Int. Immunol. 18: 1221-1232.